Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. / Kreiner, Frederik; Galbo, Henrik.

I: Arthritis Research & Therapy, Bind 12, Nr. 5, 01.01.2010, s. R176.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Kreiner, F & Galbo, H 2010, 'Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial', Arthritis Research & Therapy, bind 12, nr. 5, s. R176. https://doi.org/10.1186/ar3140

APA

Kreiner, F., & Galbo, H. (2010). Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. Arthritis Research & Therapy, 12(5), R176. https://doi.org/10.1186/ar3140

Vancouver

Kreiner F, Galbo H. Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. Arthritis Research & Therapy. 2010 jan. 1;12(5):R176. https://doi.org/10.1186/ar3140

Author

Kreiner, Frederik ; Galbo, Henrik. / Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. I: Arthritis Research & Therapy. 2010 ; Bind 12, Nr. 5. s. R176.

Bibtex

@article{461d0d161b6f46a0a716453a8f187a55,
title = "Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial",
abstract = "To elucidate in polymyalgia rheumatica (PMR) the role of tumor necrosis factor (TNF) a and the therapeutic potential of blockade with soluble TNF-a receptor, we carried out the first randomized controlled trial with etanercept in PMR.",
author = "Frederik Kreiner and Henrik Galbo",
year = "2010",
month = jan,
day = "1",
doi = "http://dx.doi.org/10.1186/ar3140",
language = "English",
volume = "12",
pages = "R176",
journal = "Arthritis Research & Therapy",
issn = "1478-6354",
publisher = "BioMed Central",
number = "5",

}

RIS

TY - JOUR

T1 - Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial

AU - Kreiner, Frederik

AU - Galbo, Henrik

PY - 2010/1/1

Y1 - 2010/1/1

N2 - To elucidate in polymyalgia rheumatica (PMR) the role of tumor necrosis factor (TNF) a and the therapeutic potential of blockade with soluble TNF-a receptor, we carried out the first randomized controlled trial with etanercept in PMR.

AB - To elucidate in polymyalgia rheumatica (PMR) the role of tumor necrosis factor (TNF) a and the therapeutic potential of blockade with soluble TNF-a receptor, we carried out the first randomized controlled trial with etanercept in PMR.

U2 - http://dx.doi.org/10.1186/ar3140

DO - http://dx.doi.org/10.1186/ar3140

M3 - Journal article

VL - 12

SP - R176

JO - Arthritis Research & Therapy

JF - Arthritis Research & Therapy

SN - 1478-6354

IS - 5

ER -

ID: 34109561